BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 11035317)

  • 1. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
    Hogg BB; Tamura T; Johnston KE; Dubard MB; Goldenberg RL
    Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increase of hemoglobin concentration in blood during the second trimester of pregnancy in relation to later pregnancy complications such as hypertension and intrauterine fetal growth inhibition].
    Jendryczko A; Tomala J
    Wiad Lek; 1993 Mar; 46(5-6):201-5. PubMed ID: 8249398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma homocysteine concentration and its relationship with the development of preeclampsia. Effect of prenatal administration of folic acid].
    Fernández M; Fernández G; Diez-Ewald M; Torres E; Vizcaíno G; Fernández N; Narváez J; Arteaga-Vizcaíno M
    Invest Clin; 2005 Jun; 46(2):187-95. PubMed ID: 16001750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma volume determination in pregnancies complicated by chronic hypertension and intrauterine fetal demise.
    Sibai BM; Abdella TN; Anderson GD; McCubbin JH
    Obstet Gynecol; 1982 Aug; 60(2):174-8. PubMed ID: 7155477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction.
    Sabatier F; Bretelle F; D'ercole C; Boubli L; Sampol J; Dignat-George F
    Am J Obstet Gynecol; 2000 Dec; 183(6):1558-63. PubMed ID: 11120528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?
    Chammas MF; Nguyen TM; Li MA; Nuwayhid BS; Castro LC
    Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum homocysteine level and its association with folic acid and vitamin B12 in the third trimester of pregnancies complicated with intrauterine growth restriction.
    Gadhok AK; Sinha M; Khunteta R; Vardey SK; Upadhyaya C; Sharma TK; Jha M
    Clin Lab; 2011; 57(11-12):933-8. PubMed ID: 22239024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia.
    Yu CK; Lakasing L; Papageorghiou AT; Spencer K; Nicolaides KH
    J Matern Fetal Neonatal Med; 2004 Aug; 16(2):134-9. PubMed ID: 15512726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia.
    Makedos G; Papanicolaou A; Hitoglou A; Kalogiannidis I; Makedos A; Vrazioti V; Goutzioulis M
    Arch Gynecol Obstet; 2007 Feb; 275(2):121-4. PubMed ID: 16941105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between maternal plasma homocysteine and zinc levels in preeclamptic women.
    Harma M; Harma M; Kocyigit A
    Biol Trace Elem Res; 2005 May; 104(2):97-105. PubMed ID: 15894810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
    Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
    Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of plasma fibronectin levels in pregnancy induced hypertension.
    Paneva-Masin J; Zafirovska K; Bogdanovska S; Lozance L; Gerasimovska B
    Acta Med Croatica; 2000; 54(4-5):157-60. PubMed ID: 11379479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia.
    Cotter AM; Molloy AM; Scott JM; Daly SF
    Am J Obstet Gynecol; 2001 Oct; 185(4):781-5. PubMed ID: 11641651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
    Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
    Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
    Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.